ATRI - Dividend announcements

ALLEN, Texas, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ:ATRI) today announced its results for the second quarter ended June 30, 2024. Revenues for the second quarter of 2024 totaled $48.8 million compared to $43.8 million for the same period in 2023. For the just ended quarter, operating income was $0.5 million, down $6.8 million from the comparable 2023 period, and net income was $0.4 million, down $6.2 million from the same period in 2023. Operating income was significantly impacted by the accrual of $5.0 million in acquisition-related expenses discussed below. Second quarter 2024 diluted earnings per share were $0.23 compared to $3.73 for the second quarter of 20

ALLEN, Texas, May 21, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ:ATRI) today announced that its Board of Directors declared a quarterly dividend of $2.20 per share on its outstanding shares of Common Stock. This dividend will be payable on June 28, 2024 to stockholders of record at the close of business on June 14, 2024. Atrion Corporation develops and manufactures products primarily for medical applications. The Company's website is www.atrioncorp.com. Contact: Cindy FergusonVice President and Chief Financial Officer(972) 390-9800         

ALLEN, Texas, May 10, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ:ATRI) today announced its results for the first quarter ended March 31, 2024. Revenues for the first quarter of 2024 totaled $47.3 million compared to $40.0 million for the same period in 2023. For the just ended quarter, operating income was $3.1 million, down $1.3 million from the comparable 2023 period, primarily due to a one-time inventory write-off, and net income was $2.8 million, down $0.7 million from the same period in 2023. First quarter 2024 diluted earnings per share were $1.59 compared to $1.98 for the first quarter of 2023. Commenting on the results for the first quarter of 2024 compared to the prior

ALLEN, Texas, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ:ATRI) today announced its results for the fourth quarter ended December 31, 2023 and the full year 2023. For the fourth quarter of 2023 compared to the fourth quarter of 2022, revenues were $43.6 million, up $729 thousand, operating income was $6.7 million, down $2.1 million, and net income was $6.4 million, down $1.9 million. Fourth quarter 2023 diluted earnings per share were $3.65 compared to $4.70 for the fourth quarter of 2022. Commenting on 2023 quarterly results compared to the comparable 2022 periods, David Battat, President and CEO, stated, "Looking at the 2023 and comparable 2022 quarters sequentially, w

ALLEN, Texas, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ:ATRI) today announced that its Board of Directors declared a quarterly dividend of $2.20 per share on its outstanding shares of Common Stock. This dividend will be payable on December 15, 2023 to stockholders of record at the close of business on December 1, 2023. Atrion Corporation develops and manufactures products primarily for medical applications. The Company's website is www.atrioncorp.com. Contact:Cindy Ferguson Vice President and Chief Financial Officer (972) 390-9800  

ALLEN, Texas, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ:ATRI) today announced its results for the third quarter ended September 30, 2023. Revenues for the third quarter of 2023 totaled $41.9 million compared to $44.6 million for the same period in 2022. For the quarter ended September 30, 2023, operating income was $4.1 million, down $5.5 million from the comparable 2022 period, and net income was $2.9 million, down $5.9 million from the same period in 2022. Third quarter 2023 diluted earnings per share were $1.67 compared to $4.94 for the third quarter of 2022. Commenting on the results for the third quarter of 2023, David Battat, President and CEO, stated, "As was th

ALLEN, Texas, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ:ATRI) today announced an increase in its quarterly cash dividend from $2.15 per share to $2.20 per share. At today's meeting, the Board of Directors declared a quarterly dividend of $2.20 per share on its outstanding shares of Common Stock. This dividend will be payable on September 29, 2023, to stockholders of record at the close of business on September 15, 2023. Atrion Corporation develops and manufactures products primarily for medical applications. The Company's website is www.atrioncorp.com.  Contact: Cindy Ferguson Vice President and Chief Financial Officer (972) 390-9800

ALLEN, Texas, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ:ATRI) today announced its results for the second quarter ended June 30, 2023. Revenues for the second quarter of 2023 totaled $43.8 million compared to $48.9 million for the same period in 2022. For the quarter ended June 30, 2023, operating income was $7.4 million, down $3.7 million from the comparable 2022 period, and net income was $6.6 million, down $2.8 million from the same period in 2022. Second quarter 2023 diluted earnings per share were $3.73 compared to $5.20 for the second quarter of 2022. Commenting on the results for the second quarter of 2023 compared to the prior year period, David Battat, Presiden

ALLEN, Texas, May 23, 2023 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ:ATRI) today announced that its Board of Directors declared a quarterly dividend of $2.15 per share on its outstanding shares of Common Stock. This dividend will be payable on June 30, 2023 to stockholders of record at the close of business on June 15, 2023. Atrion Corporation develops and manufactures products primarily for medical applications. The Company's website is www.atrioncorp.com. Contact:Cindy Ferguson Vice President and Chief Financial Officer (972) 390-9800

ALLEN, Texas, May 08, 2023 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ:ATRI) today announced its results for the first quarter ended March 31, 2023. Revenues for the first quarter of 2023 totaled $40.0 million compared to $47.1 million for the same period in 2022. For the quarter ended March 31, 2023, operating income was $4.5 million, down $5.8 million from the comparable 2022 period, and net income was $3.5 million, down $5.0 million from the same period in 2022. First quarter 2023 diluted earnings per share were $1.98 compared to $4.71 for the first quarter of 2022. Commenting on the results for the first quarter of 2023 compared to the prior year period, David Battat, President an

ALLEN, Texas, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ:ATRI) today announced its results for the fourth quarter ended December 31, 2022 and the full year 2022. Revenues for the fourth quarter of 2022 totaled $42.9 million compared to $40.3 million for the same period in 2021. For the quarter ended December 31, 2022, operating income was $8.8 million, up $967 thousand over the comparable 2021 period, and net income was $8.3 million, up $195 thousand over the same period in 2021. Fourth quarter 2022 diluted earnings per share were $4.70 compared to $4.50 for the fourth quarter of 2021. For the full year 2022 compared to the full year 2021, revenues increased to $183.5

ALLEN, Texas, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ:ATRI) today announced that its Board of Directors declared a quarterly dividend of $2.15 per share on its outstanding shares of Common Stock. This dividend will be payable on March 31, 2023 to stockholders of record at the close of business on March 15, 2023. Atrion Corporation develops and manufactures products primarily for medical applications. The Company's website is www.atrioncorp.com. Contact:Jeffery Strickland Vice President and Chief Financial Officer (972) 390-9800

ALLEN, Texas, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ:ATRI) today announced that its Board of Directors declared a quarterly dividend of $2.15 per share on its outstanding shares of Common Stock. This dividend will be payable on December 15, 2022 to stockholders of record at the close of business on December 1, 2022. Atrion Corporation develops and manufactures products primarily for medical applications. The Company's website is www.atrioncorp.com. Contact:Jeffery Strickland Vice President and Chief Financial Officer (972) 390-9800

ALLEN, Texas, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ:ATRI) today announced its results for the third quarter ended September 30, 2022. Revenues for the third quarter of 2022 totaled $44.6 million compared to $42.9 million for the same period in 2021. For the quarter ended September 30, 2022, operating income was $9.6 million, up $125 thousand over the comparable 2021 period, and net income was $8.8 million, up $562 thousand over the same period in 2021. Third quarter 2022 diluted earnings per share were $4.94 compared to $4.58 for the third quarter of 2021. Commenting on the results for the third quarter of 2022 compared to the prior year period, David Battat, P

ALLEN, Texas, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Atrion Corporation (Nasdaq ATRI) today announced an increase in its quarterly cash dividend from $1.95 per share to $2.15 per share. Specifically, the Board of Directors declared a quarterly cash dividend of $2.15 per share on its outstanding shares of Common Stock. This dividend will be payable on September 30, 2022 to stockholders of record at the close of business on September 15, 2022. Atrion Corporation develops and manufactures products primarily for medical applications. The Company's website is www.atrioncorp.com. Contact:        Jeffery StricklandVice President and Chief Financial Officer(972) 390-9800

ALLEN, Texas, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ:ATRI) today announced its results for the second quarter ended June 30, 2022. Revenues for the second quarter of 2022 totaled $48.9 million compared to $42.7 million for the same period in 2021. For the quarter ended June 30, 2022, operating income was $11.0 million, up $1.2 million over the comparable 2021 period, and net income was $9.3 million, up $424 thousand over the same period in 2021. Second quarter 2022 diluted earnings per share were $5.20 compared to $4.88 for the second quarter of 2021. Commenting on the results for the second quarter of 2022 compared to the prior year period, David Battat, President

ALLEN, Texas, May 24, 2022 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ:ATRI) today announced that its Board of Directors declared a quarterly dividend of $1.95 per share on its outstanding shares of Common Stock. This dividend will be payable on June 30, 2022 to stockholders of record at the close of business on June 15, 2022. Atrion Corporation develops and manufactures products primarily for medical applications. The Company's website is www.atrioncorp.com. Contact:Jeffery Strickland Vice President and Chief Financial Officer (972) 390-9800

ALLEN, Texas, May 09, 2022 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ:ATRI) today announced its results for the first quarter ended March 31, 2022. Revenues for the first quarter of 2022 totaled $47.1 million compared to $39.2 million for the same period in 2021. For the quarter ended March 31, 2022, operating income was $10.3 million, up $1.3 million over the comparable 2021 period, and net income was $8.5 million, up $800 thousand over the same period in 2021. First quarter 2022 diluted earnings per share were $4.71 compared to $4.22 for the first quarter of 2021. Commenting on the results for the first quarter of 2022 compared to the prior year period, David Battat, President

ALLEN, Texas, Feb. 25, 2022 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ:ATRI) today announced its results for the fourth quarter ended December 31, 2021 and the full year 2021. Revenues for the fourth quarter of 2021 totaled $40.3 million compared to $32.2 million for the same period in 2020. Net income for the fourth quarter of 2021 totaled $8.1 million, an increase of $0.7 million compared to the same period in 2020. Fourth quarter 2021 diluted earnings per share were $4.50 compared to $4.02 for the fourth quarter of 2020. For the full year 2021 compared to the full year 2020, revenues increased to $165.0 million from $147.6 million, net income was $33.1 million versus $32.1 mill

ALLEN, Texas, Feb. 25, 2022 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ:ATRI) today announced that its Board of Directors declared a quarterly dividend of $1.95 per share on its outstanding shares of Common Stock. This dividend will be payable on March 31, 2022 to stockholders of record at the close of business on March 15, 2022. Atrion Corporation develops and manufactures products primarily for medical applications. The Company's website is www.atrioncorp.com. Contact:Jeffery Strickland Vice President and Chief Financial Officer (972) 390-9800                                               

ALLEN, Texas, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ:ATRI) today announced that its Board of Directors declared a quarterly dividend of $1.95 per share on its outstanding shares of Common Stock. This dividend will be payable on December 15, 2021 to stockholders of record at the close of business on December 1, 2021. Atrion Corporation develops and manufactures products primarily for medical applications. The Company's website is www.atrioncorp.com. Contact:Jeffery Strickland Vice President and Chief Financial Officer (972) 390-9800

ALLEN, Texas, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ:ATRI) today announced its results for the third quarter ended September 30, 2021. Revenues totaled $42.9 million compared to $33.8 million for the same period in 2020. Net income for the third quarter of 2021 totaled $8.3 million, an increase of $1.1 million compared to $7.2 million for the same period in 2020, with diluted earnings per share for the third quarter of 2021 at $4.58 compared to $3.95 for the third quarter of 2020. Commenting on the results for the third quarter, David Battat, President and CEO, stated, "We have spent this year focusing on expanding our customer base, increasing business with existin

ALLEN, Texas, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Atrion Corporation (Nasdaq ATRI) today announced an increase in its quarterly cash dividend from $1.75 per share to $1.95 per share. Specifically, the Board of Directors declared a quarterly dividend of $1.95 per share on its outstanding shares of Common Stock. This dividend will be payable on September 30, 2021 to stockholders of record at the close of business on September 15, 2021. Atrion Corporation develops and manufactures products primarily for medical applications. The Company's website is www.atrioncorp.com. Contact:Jeffery Strickland Vice President and Chief Financial Officer (972) 390-9800  

ALLEN, Texas, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ:ATRI) today announced that for the second quarter ended June 30, 2021, revenues totaled $42.7 million compared with $38.0 million for the same period in 2020. Net income for the second quarter of 2021 totaled $8.9 million as compared to $8.6 million for the same period in 2020, with diluted earnings per share for the second quarter of 2021 at $4.88 compared to $4.68 for the second quarter of 2020. Commenting on results for the second quarter of 2021, David Battat, President and CEO, stated, "In our press release announcing first quarter 2021 results, we highlighted that after three consecutive pandemic quarterly de

ALLEN, Texas, May 21, 2021 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ:ATRI) today announced that its Board of Directors declared a quarterly dividend of $1.75 per share on its outstanding shares of Common Stock. This dividend will be payable on June 30, 2021 to stockholders of record at the close of business on June 15, 2021. Atrion Corporation develops and manufactures products primarily for medical applications. The Company's website is www.atrioncorp.com. Contact: Jeffery StricklandVice President and Chief Financial Officer(972) 390-9800

ALLEN, Texas, May 10, 2021 (GLOBE NEWSWIRE) -- Atrion Corporation (Nasdaq - ATRI) today announced that revenues for the quarter ended March 31, 2021 were $39.2 million compared with $43.6 million for the first quarter of 2020. Net income in the current-year quarter totaled $7.7 million compared to $8.9 million in last year's first quarter, with diluted earnings per share for the first quarter of 2021 at $4.22 compared to $4.79 for the first quarter of 2020. Commenting on results for the first quarter of 2021 and the outlook for the remainder of 2021, Mr. Battat stated, "I am very pleased to report strong growth in quarterly sequential sales, with revenues for the first quarter of 2021 inc

ALLEN, Texas, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) announced today that for the fourth quarter of 2020 revenues were $32.2 million compared to $34.5 million in the same period of 2019, net income was $7.4 million compared to $8.1 million in the prior year period, and diluted earnings per share were $4.02 compared to $4.33 in the prior-year period. For the full year 2020 compared to 2019, Atrion revenues declined to $147.6 million from $155.1 million, net income was $32.1 million compared to $36.8 million, and diluted earnings per share were $17.44 compared to $19.73. David Battat, President & CEO, commenting on the results for the year said, “This has been a

ALLEN, Texas, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced that its Board of Directors declared a quarterly dividend of $1.75 per share on its outstanding shares of Common Stock. This dividend will be payable on March 31, 2021 to stockholders of record at the close of business on March 15, 2021. Atrion Corporation develops and manufactures products primarily for medical applications. The Company’s website is www.atrioncorp.com. Contact: Jeffery Strickland  Vice President and Chief Financial Officer  (972) 390-9800 Related Articles More articles issued by Atrion Corporation More art